Leishmania donovani induces interferon regulatory factor in murine macrophages: A host defense response

Biochemical and Biophysical Research Communications

Volumn 317, Issue 2, 2004, Pages 639-647

  Balaraman, Sridevi ^a   Tewary, Poonam ^a   Singh, Vandana Km ^a   Madhubala, Rentala ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

IRF 1; Leishmania donovani; Macrophages; Transcription factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERFERON REGULATORY FACTOR 1; LIPOPHOSPHOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING KINETICS; CONCENTRATION (PARAMETERS); HOST PARASITE INTERACTION; HOST RESISTANCE; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TIME; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSPHINGOLIPIDS; HOST-PARASITE RELATIONS; INTERFERON REGULATORY FACTOR-1; LEISHMANIA DONOVANI; MACROPHAGES; MICE; PHOSPHOPROTEINS;

LEISHMANIA DONOVANI; MURINAE;

EID: 1842426008     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.097     Document Type: Article

References (39)

1. Chan J., Fujiwara T., Brennan P., McNeil M., Turco S.J., Sibille J.C., Snapper M., Aisen P., Bloom B.R. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA. 86:1989;2453-2457.
2. Descoteaux A., Turco S.J., Sacks D.L., Matlashewski G. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J. Immunol. 146:1991;2747-2753.
3. Desjardins M., Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:1997;2061-2068.
4. McNeely T.B., Turco S.J. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J. Immunol. 144:1990;2745-2750.
5. Piedrafita D., Proudfoot L., Nikolaev A.V., Xu D., Sands W., Feng G.J., Thomas E., Brewer J., Ferguson M.A., Alexander J., Liew F.Y. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur. J. Immunol. 29:1999;235-244.
6. Proudfoot L., Nikolaev A.V., Feng G.J., Wei W.Q., Ferguson M.A., Brimacombe J.S., Liew F.Y. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA. 93:1996;10984-10989.
7. Puentes S.M., Sacks D.L., da Silva R.P., Joiner K.A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J. Exp. Med. 167:1988;887-902.
8. Prive C., Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naïve macrophages. Eur. J. Immunol. 30:2000;2235-2244.
9. Scharton-Kersten T., Contursi C., Masumi A., Sher A., Ozato K. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1997;1523-1534.
10. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.H., Kojima S., Taniguchi T., Asano Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679.
11. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 15:1995;5258-5267.
12. Griscavage J.M., Wilk S., Ignarro L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA. 93:1996;3308-3312.
13. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J. 7:1998;3397-3405.
14. Miyamoto N., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1 that specifically binds to IFN-beta gene regulatory elements. Cell. 54:1988;903-913.
15. Lin R., Mustafa A., Nguyen H., Gewert D., Hiscott J. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. J. Biol. Chem. 269:1994;17542-17549.
16. Fujita T., Reis L.F., Watanabe N., Kimura Y., Taniguchi T., Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA. 86:1989;9936-9940.
17. Yu Lee L.Y., Hrachovy J.A., Stevens A.M., Schwarz L.A. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol. Cell. Biol. 10:1990;3087-3094.
18. Tanaka N., Kawakami T., Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:1993;4531-4538.
19. Ohno S., Taniguchi T. The 5'-flanking sequence of human interferon-beta 1 gene is responsible for viral induction of transcription. Nucleic Acids Res. 11:1983;5403-5412.
20. Johnson D.R., Pober J.S. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1994;1322-1332.
21. Benech P., Vigneron M., Peretz D., Revel M., Chebath J. Interferon-responsive regulatory elements in the promoter of the human 25 oligo (A) synthetase gene. Mol. Cell. Biol. 7:1987;4498-4504.
22. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
23. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.J., Mak T.W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
24. Feng G.J., Goodridge H.S., Harnett M.M., Wei X.Q., Nikolaev A.V., Higson A.P., Liew F.Y. Extracellular Signal-Related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophage: Leishmania phosphoglycans subvert macrophages IL-12 production by targeting ERK MAP kinase. J. Immunol. 163:1999;6403-6412.
25. Qiao Y., Prabhakar S., Coccia E.M., Weiden M., Canova A., Giacomini E., Pine R. Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor. J. Biol. Chem. 277:2002;22377-22385.
26. Barber S.A., Fultz M.J., Salkowski C.A., Vogel S.N. Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2 and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63:1995;601-608.
27. Hart D.T., Vickerman K., Coombs G.H. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology. 82:1981;345-355.
28. Orlandi P.A. Jr., Turco S.J. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J. Biol. Chem. 262:1987;10384-10391.
29. Russo D.M., Turco S.J., Burns J.M. Jr., Reed S.G. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J. Immunol. 148:1992;202-207.
30. Rao P., Pattabiraman T.N. Reevaluation of the phenol-sulfuric acid reaction for the estimation of hexoses and pentoses. Anal. Biochem. 181:1989;18-22.
31. Schreiber E., Martthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
32. Chaturvedi M.M., La Pushin R., Aggarwal B.B. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response. J. Biol. Chem. 269:1994;14575-14583.
33. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
34. Grassme H.U., Ireland R.M., van Putten J.P. Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton. Infect. Immun. 64:1996;1621-1630.
35. Naumann M., Weßler S., Bartsch C., Weiland B., Meyer T.F. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor κB and activator protein 1 and the induction of inflammatory cytokines. J. Exp. Med. 186:1997;247-258.
36. Nguyen H., Hiscott J., Pitha P. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev. 8:1997;293-312.
37. Pine R. IRF and tuberculosis. J. Interferon Cytokine Res. 22:2002;15-25.
38. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollonghoft M., Mak T.W. Interferon regulatory factor-1 is required for T helper 1 immune response in vivo. Immunity. 6:1997;681-689.
39. Feng C., Watanabe S., Maruyama S., Suzuki G., Sato M., Furuta T., Kojima S., Taki S., Asano Y. An alternate pathway for type 1 T cell differentiation. Int. Immunol. 11:1999;1185-1194.